Ovarian Cancer Trial, Recruiting NCT06279104 Sponsor: Tongji Hospital Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Recruiting

NCT06279104
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women aged 18 to 75 years old
  • People who have been diagnosed with ovarian clear cell carcinoma (a specific type of ovarian cancer), confirmed by a tissue sample test
  • People whose ovarian clear cell carcinoma has come back or has not gone away, and who have already received at least one round of platinum-based chemotherapy treatment
  • People whose general health and ability to carry out daily activities meets a certain minimum level, as measured by a standard medical scoring system called the ECOG scale (score of 2 or below — confirm with trial site for details)
  • People whose doctors estimate they are expected to live at least 12 weeks

Who may not be able to join:

  • People whose tissue sample results show a type of cancer that is not ovarian clear cell carcinoma

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 13871127473

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Tongji Hospital
Registry
ClinicalTrials.gov
Start date
1 March 2023
Est. completion
1 May 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

tumor response rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov